V-CARD

PHONE
+1 202 637 5789
FAX
+1 202 637 5910
|
|
Robert
F.
Leibenluft
Partner, Washington, D.C.
robert.leibenluft@hoganlovells.com
Bob Leibenluft's practice is devoted entirely to health and antitrust matters, including counseling and litigation regarding antitrust issues involving hospitals, physicians, health plans, drug and medical device manufacturers, and other entities in the health care sector.
Upon completing law school, Bob worked as an attorney advisor in the Federal Trade Commission (FTC)'s Office of Policy Planning, concentrating on health and antitrust matters. In 1981, he joined Hogan & Hartson and became a partner in the firm in 1989. He practiced health law at Hogan & Hartson until January 1996 when he rejoined the FTC as Assistant Director for Health Care in the FTC's Bureau of Competition. As head of the Health Care Division, Bob supervised a 25-30 person staff engaged in the review of mergers, acquisitions, and joint ventures involving hospitals, physicians, and other healthcare providers, as well as conduct in the healthcare and pharmaceutical industries. He rejoined Hogan & Hartson in September 1998.
Bob writes and lectures extensively on antitrust and health law topics. His articles on healthcare matters have appeared in Health Affairs, The New England Journal of Medicine, Vanderbilt Law Review, The American Journal of Psychiatry, Business and Health, Pharmaceutical Executive, Medical Device & Diagnostic Industry, and other books and journals.
Hogan Lovells Publications
08 December 2011
"Life Sciences Antitrust and Competition Newsletter." Life Sciences: Competition & Antitrust Alert, Issue 18, Hogan Lovells
27 October 2011
"Insights and implications of CMS ACO final rule." Health Alert, Hogan Lovells
08 April 2011
"Implications of federal agencies' proposed guidance on accountable care organizations." Health Alert, Hogan Lovells
02 December 2010
"Life Sciences: Competition and Antitrust Newsletter, Issue 17.", Hogan Lovells
23 July 2010
"Life Sciences: Competition and Antitrust Alert, Issue 16." Competition and Antitrust Alert, Hogan Lovells
Published Works
May 2012
"Pharmaceutical Antitrust 2012: US Chapter." Getting the Deal Through, Law Business Research Ltd.
December 2011
"The ACO Antitrust Policy Statement: Antitrust Enforcement Meets Regulatory Rulemaking." The Antitrust Source, American Bar Association, December 2011
17 March 2011
"FTC Loses Lundbeck Drug Acquisition Challenge." International Law Office
22 December 2010
"ACOs and the Enforcement of Fraud, Abuse, and Antitrust Laws." The New England Journal of Medicine
19 July 2010
"Pharmaceutical life cycle management under the UK competition spotlight." European Pharmaceutical Contractor
|
|
|